ES2187525T3 - Mejora de la viabilidad de las celulas bacterianas secas. - Google Patents

Mejora de la viabilidad de las celulas bacterianas secas.

Info

Publication number
ES2187525T3
ES2187525T3 ES94921046T ES94921046T ES2187525T3 ES 2187525 T3 ES2187525 T3 ES 2187525T3 ES 94921046 T ES94921046 T ES 94921046T ES 94921046 T ES94921046 T ES 94921046T ES 2187525 T3 ES2187525 T3 ES 2187525T3
Authority
ES
Spain
Prior art keywords
viability
improvement
bacterial cells
dry bacterial
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94921046T
Other languages
English (en)
Inventor
Michael Jeremy Legg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Drug Delivery Ltd
Original Assignee
Elan Drug Delivery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Drug Delivery Ltd filed Critical Elan Drug Delivery Ltd
Application granted granted Critical
Publication of ES2187525T3 publication Critical patent/ES2187525T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA VIABILIDAD DE LAS CELULAS BACTERIANAS DESPUES DE DESHIDRATACION SE MEJORA ENVEJECIENDO EL CULTIVO EN LA FASE FIJA DURANTE PERIODOS DE APROXIMADAMENTE 6 HORAS ANTES DE LA DESHIDRATACION. ADEMAS LA MEJORA SE PUEDE OBTENER POR CULTIVO EN UN MEDIO DEFICIENTE EN NITROGENO.
ES94921046T 1993-07-19 1994-07-19 Mejora de la viabilidad de las celulas bacterianas secas. Expired - Lifetime ES2187525T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314886A GB9314886D0 (en) 1993-07-19 1993-07-19 Production of a biological control agent

Publications (1)

Publication Number Publication Date
ES2187525T3 true ES2187525T3 (es) 2003-06-16

Family

ID=10739028

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94921046T Expired - Lifetime ES2187525T3 (es) 1993-07-19 1994-07-19 Mejora de la viabilidad de las celulas bacterianas secas.

Country Status (9)

Country Link
US (1) US5728574A (es)
EP (1) EP0663947B1 (es)
AT (1) ATE230019T1 (es)
AU (1) AU688775B2 (es)
DE (1) DE69431903D1 (es)
DK (1) DK0663947T3 (es)
ES (1) ES2187525T3 (es)
GB (1) GB9314886D0 (es)
WO (1) WO1995003395A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673335B1 (en) * 1992-07-08 2004-01-06 Nektar Therapeutics Compositions and methods for the pulmonary delivery of aerosolized medicaments
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
ATE220327T1 (de) * 1992-09-29 2002-07-15 Inhale Therapeutic Syst Pulmonale abgabe von aktiven fragmenten des parathormons
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
ES2218543T3 (es) * 1994-03-07 2004-11-16 Nektar Therapeutics Procedimiento y preparacion para la administracion de insulina por via pulmonar.
NZ285664A (en) * 1994-05-18 1998-07-28 Inhale Therapeutic Syst Dry powder interferon composition adapted for pulmonary delivery
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
CZ88697A3 (en) 1994-09-22 1997-09-17 Quadrant Holdings Cambridge Composition used for re-hydration and nourishment in the course of athletic outputs and processes for preparing thereof
US6468782B1 (en) * 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US20030035778A1 (en) * 1997-07-14 2003-02-20 Robert Platz Methods and compositions for the dry powder formulation of interferon
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
EP1402003A4 (en) * 1999-08-19 2004-07-14 Universal Preservation Technologies Inc Preservation of bacterial cells below room temperature
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU2001280934A1 (en) * 2000-07-28 2002-02-13 Alliance Pharmaceutical Corp. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
WO2003024211A2 (en) * 2001-09-14 2003-03-27 Invitrogen Corporation Composition for stabilizing biological materials
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US6927062B2 (en) * 2002-11-25 2005-08-09 Agdia, Inc. Controls and standards for assays and method for manufacture thereof
US20050095320A1 (en) * 2003-10-29 2005-05-05 Richard Botteri [An Isotonic Sports Drink for Female Athletes Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Nutrition During Execise and Competition]
US20050100636A1 (en) * 2003-11-10 2005-05-12 Megan Botteri [A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity]
EP2434016B1 (en) 2004-01-16 2018-11-07 Pfenex Inc. Expression of mammalian proteins in pseudomonas fluorescens
EP1774017B1 (en) 2004-07-26 2013-05-15 Pfenex Inc. Process for improved protein expression by strain engineering
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
WO2014060427A2 (en) 2012-10-16 2014-04-24 Universitaet Des Saarlandes Electrocompetent cells and preparation thereof
US10982185B2 (en) 2018-09-26 2021-04-20 The United States Of America, As Represented By The Secretary Of Agriculture Desiccation resistant pseudomonad strains and treatment of agricultural maladies therewith
AU2020260716B2 (en) 2019-04-26 2026-03-12 International N&H Denmark Aps Probiotic strains having increased storage stability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236761A (en) * 1951-01-28 1966-02-22 Union Carbide Corp Hydrocarbon conversion process and catalyst
US3261761A (en) * 1962-05-07 1966-07-19 Arthur W Anderson Method of freeze drying bacterial cultures
GB1134199A (en) * 1965-04-27 1968-11-20 Pfizer & Co C Frozen concentrated milk-acidulating culture
FR2482130A1 (fr) * 1980-05-12 1981-11-13 Lumer Ste Indle Produits Chimi Procede de preparation d'un inoculum pour l'entretien de fosses septiques et analogues, comportant des micro-organismes deshydrates et des enzymes, et inoculums prepares par ce procede
GB8700354D0 (en) * 1987-01-08 1987-02-11 Distillers Co Culture of micro-organisms
US5288634A (en) * 1990-08-03 1994-02-22 Cornell Research Foundation, Inc. Method of increasing the percentage of viable dried spores of a fungus

Also Published As

Publication number Publication date
EP0663947A1 (en) 1995-07-26
US5728574A (en) 1998-03-17
DK0663947T3 (da) 2003-03-24
DE69431903D1 (de) 2003-01-30
ATE230019T1 (de) 2003-01-15
GB9314886D0 (en) 1993-09-01
EP0663947B1 (en) 2002-12-18
WO1995003395A1 (en) 1995-02-02
AU688775B2 (en) 1998-03-19
AU7192094A (en) 1995-02-20

Similar Documents

Publication Publication Date Title
SE8802165D0 (sv) Improvements in and relating to fermentation
ES2165368T3 (es) Cultivo de celulas animales.
ATE221069T1 (de) Pentafluorophenylazolopyrimidine
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
DK470187A (da) Fremgangsmaade til konservering af maelkesyrebakterier
DK0397336T3 (da) Cellevækstinhibitoriske makrocycliske lactoner benævnte combretastatin D-1 og combretastatin D-2
DE69431903D1 (de) Verbesserung der lebensfähigkeit von getrockneten bakterienzellen
EP0267723A3 (en) New substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
FI885436A7 (fi) Fermenttori soluviljelmien viljelemiseksi
ES2168276T3 (es) 1-arilsulfonil-3-fenil-1,4,5,6-tetrahidropiridazinas.
ES2041249T3 (es) Preparaciones liquidas de 1,2-benzoisotiazolin-3-ona, su obtencion y empleo.
SE8100005L (sv) Vattenhaltiga kompositioner innehallande stabiliserade enzymer
FI881225A0 (fi) Medel foer att foerbaettra jordmaonen och vaextligheten och bibehaolla deras naturliga sundhet samt motsvarande foerfarande.
FI914477A0 (fi) Mikrobiologiskt foerfarande foer framstaellning av hydroxylerade heterocykliska foereningar.
SE8701456D0 (sv) Immunostimulerande tripeptider
ES2141123T3 (es) Preparacion de antitrombina iii.
DK320589A (da) Fremgangsmaade til hindring af vaekst af aerobe fungi i vandige carbonhydrider
BG34454A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
FI895082A7 (fi) Bakteeribiomassalannoite
RO90918A2 (ro) Tulpina de ciuperci de cultura(agaricus campestris l.var bisporus lange(moller et schaeffer)"bulgare de zapada 5"
HRPK920279B1 (en) Masterbatch for pvc mass dyeing
SU1769405A1 (ru) Регулятор роста растений
KR970047031U (ko) 전지 극판의 진공건조로
KR950021542U (ko) 자동주행 청소기의 밧데리 케이스
IE872787L (en) Endothelial cell harvesting kit